Risk of vigabatrin‐associated brain abnormalities on <scp>MRI</scp> in the treatment of infantile spasms is dose‐dependent

Shaun A. Hussain, Jackie Tsao, Menglu Li, Madeline D. Schwarz, Raymond Zhou, Joyce Y. Wu, Noriko Salamon, Raman SankarEpilepsia 2017 · DOI

Abstract

We have demonstrated dose-dependent risk of asymptomatic VABAM and uncovered a possible association between symptomatic VABAM and concomitant hormonal therapy. Caution should be exercised in the use of high VGB dosage (i.e., >175 mg/kg/day), and further study is warranted to confirm the potential impact of hormonal therapy.
BibTeX
@inproceedings{hussain2017risk,
  author = {Shaun A. Hussain and Jackie Tsao and Menglu Li and Madeline D. Schwarz and Raymond Zhou and Joyce Y. Wu and Noriko Salamon and Raman Sankar},
  title = {{Risk of vigabatrin‐associated brain abnormalities on <scp>MRI</scp> in the treatment of infantile spasms is dose‐dependent}},
  booktitle = {Epilepsia},
  year = {2017},
  doi = {10.1111/epi.13712},
}

Loading related content...

Figure